These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37475475)

  • 21. Long-Term Outcome of Left Atrial Voltage-Guided Substrate Ablation During Atrial Fibrillation: A Novel Adjunctive Ablation Strategy.
    Yagishita A; Gimbel JR; DE Oliveira S; Manyam H; Sparano D; Cakulev I; Mackall J; Arruda M
    J Cardiovasc Electrophysiol; 2017 Feb; 28(2):147-155. PubMed ID: 27862561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2015 Apr; 12(4):836-44. PubMed ID: 25546810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal cutoff value of bipolar low-voltage in electroanatomic voltage mapping during atrial fibrillation rhythm.
    Kawaji T; Hojo S; Kushiyama A; Nakatsuma K; Kaneda K; Kato M; Yokomatsu T; Miki S
    Pacing Clin Electrophysiol; 2019 Jun; 42(6):663-669. PubMed ID: 30873619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients.
    Liu HT; Yang CH; Lee HL; Chang PC; Wo HT; Wen MS; Wang CC; Yeh SJ; Chou CC
    PLoS One; 2021; 16(12):e0260834. PubMed ID: 34855901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late Sodium Current in Human Atrial Cardiomyocytes from Patients in Sinus Rhythm and Atrial Fibrillation.
    Poulet C; Wettwer E; Grunnet M; Jespersen T; Fabritz L; Matschke K; Knaut M; Ravens U
    PLoS One; 2015; 10(6):e0131432. PubMed ID: 26121051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Major Role of
    Berenfeld O
    Clin Med Insights Cardiol; 2016; 10(Suppl 1):71-79. PubMed ID: 28096699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological remodeling in human atrial fibrillation.
    Van Wagoner DR
    Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 2):1572-5. PubMed ID: 12914605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
    Kohajda Z; Virág L; Hornyik T; Husti Z; Sztojkov-Ivanov A; Nagy N; Horváth A; Varga R; Prorok J; Szlovák J; Tóth N; Gazdag P; Topal L; Naveed M; Árpádffy-Lovas T; Pászti B; Magyar T; Koncz I; Déri S; Demeter-Haludka V; Aigner Z; Ördög B; Patfalusi M; Tálosi L; Tiszlavicz L; Földesi I; Jost N; Baczkó I; Varró A
    Br J Pharmacol; 2022 Jul; 179(13):3382-3402. PubMed ID: 35106755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models.
    Varela M; Colman MA; Hancox JC; Aslanidi OV
    PLoS Comput Biol; 2016 Dec; 12(12):e1005245. PubMed ID: 27984585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.
    Limantoro I; De Vos CB; Delhaas T; Marcos E; Blaauw Y; Weijs B; Tieleman RG; Pisters R; Schotten U; Van Gelder IC; Crijns HJ
    Heart Rhythm; 2014 Mar; 11(3):478-84. PubMed ID: 24321238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial fibrillation risk scores to evaluate left atrial substrate based on voltage analysis in long-standing persistent type of arrhythmia.
    Kiedrowicz RM; Wielusiński M; Wojtarowicz A; Kaźmierczak J
    Kardiol Pol; 2021; 79(5):525-530. PubMed ID: 34125925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic clamping human and rabbit atrial calcium current: narrowing I
    Kettlewell S; Saxena P; Dempster J; Colman MA; Myles RC; Smith GL; Workman AJ
    J Physiol; 2019 Jul; 597(14):3619-3638. PubMed ID: 31093979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.
    Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D
    J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
    Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts.
    Salvage SC; King JH; Chandrasekharan KH; Jafferji DI; Guzadhur L; Matthews HR; Huang CL; Fraser JA
    Acta Physiol (Oxf); 2015 Jul; 214(3):361-75. PubMed ID: 25850710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation.
    Wang Z; Pagé P; Nattel S
    Circ Res; 1992 Aug; 71(2):271-87. PubMed ID: 1628386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels.
    O' Brien S; Holmes AP; Johnson DM; Kabir SN; O' Shea C; O' Reilly M; Avezzu A; Reyat JS; Hall AW; Apicella C; Ellinor PT; Niederer S; Tucker NR; Fabritz L; Kirchhof P; Pavlovic D
    J Mol Cell Cardiol; 2022 May; 166():23-35. PubMed ID: 35114252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additional Low-Voltage-Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial.
    Masuda M; Asai M; Iida O; Okamoto S; Ishihara T; Nanto K; Kanda T; Tsujimura T; Matsuda Y; Okuno S; Hata Y; Mano T
    J Am Heart Assoc; 2020 Jul; 9(13):e015927. PubMed ID: 32578466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel approaches for pharmacological management of atrial fibrillation.
    Ehrlich JR; Nattel S
    Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.